国际眼科杂志
國際眼科雜誌
국제안과잡지
INTERNATIONAL JOURNAL OF OPHTHALMOLOGY
2015年
2期
346-348
,共3页
视网膜静脉阻塞%羟苯磺酸钙胶囊%益脉康片%临床疗效
視網膜靜脈阻塞%羥苯磺痠鈣膠囊%益脈康片%臨床療效
시망막정맥조새%간분광산개효낭%익맥강편%림상료효
retinal vein occlusion%calcium dobesilate capsule%yimaikang tablet%clinical effect
目的::观察羟苯磺酸钙胶囊联合益脉康片对视网膜静脉阻塞( retinal vein occlusion,RVO)的临床疗效。方法:将120例167眼RVO患者随机分为两组,对照组60例82眼口服羟苯磺酸钙胶囊,治疗组60例85眼口服羟苯磺酸钙胶囊和益脉康片,观察3个疗程,对治疗前后的视力、疗效进行比较。结果:治疗组60例85眼中,显效15例23眼,有效42例57眼,无效3例5眼,总有效率为94.1%;对照组60例82眼中,显效8例12眼,有效38例49眼,无效14例21眼,有效率为74.4%,两组组间不良反应发生率较低。结论:羟苯磺酸钙胶囊联合益脉康片安全有效,治疗RVO疗效显著。
目的::觀察羥苯磺痠鈣膠囊聯閤益脈康片對視網膜靜脈阻塞( retinal vein occlusion,RVO)的臨床療效。方法:將120例167眼RVO患者隨機分為兩組,對照組60例82眼口服羥苯磺痠鈣膠囊,治療組60例85眼口服羥苯磺痠鈣膠囊和益脈康片,觀察3箇療程,對治療前後的視力、療效進行比較。結果:治療組60例85眼中,顯效15例23眼,有效42例57眼,無效3例5眼,總有效率為94.1%;對照組60例82眼中,顯效8例12眼,有效38例49眼,無效14例21眼,有效率為74.4%,兩組組間不良反應髮生率較低。結論:羥苯磺痠鈣膠囊聯閤益脈康片安全有效,治療RVO療效顯著。
목적::관찰간분광산개효낭연합익맥강편대시망막정맥조새( retinal vein occlusion,RVO)적림상료효。방법:장120례167안RVO환자수궤분위량조,대조조60례82안구복간분광산개효낭,치료조60례85안구복간분광산개효낭화익맥강편,관찰3개료정,대치료전후적시력、료효진행비교。결과:치료조60례85안중,현효15례23안,유효42례57안,무효3례5안,총유효솔위94.1%;대조조60례82안중,현효8례12안,유효38례49안,무효14례21안,유효솔위74.4%,량조조간불량반응발생솔교저。결론:간분광산개효낭연합익맥강편안전유효,치료RVO료효현저。
AlM: To observe the clinical curative effect of calcium dobesilate capsule and yimaikang tablet for treating retinal vein occlusion ( RVO) .METHODS:A total of 120 patients (167 eyes) with RVO were divided into 2 groups at random. The control group of 60 cases ( 82 eyes ) were given calcium dobesilate capsule, and the treatment group of 60 cases ( 85 eyes ) received calcium dobesilate capsule and yimaikang tablet. Changes of visual acuity and clinical effects after 3 courses of treatment were compared and analyzed for all patients.RESULTS: Markedly effective 15 cases ( 23 eyes ) , effective 42 cases (57 eyes) and invalid 3 cases (5 eyes) in the 60 cases (85 eyes) of the treatment group, the total effective rate was 94. 1%. Eighty-two eyes of 60 cases in the control group, markedly effective in 8 cases ( 12 eyes), effective 38 cases (49 eyes), ineffective 14 cases (21 eyes), The total effective rate was 74. 4% in the control group. There were significant differences between the 2 groups of curative effect, and low incidence rate of adverse reaction. CONCLUSlON: Calcium dobesilate capsules and yimaikang tablet is effective and safe in the treatment of RVO.